Skip to main content
SpringerLink
Log in

Empiric guidelines for treatment of Candida infection in high-risk neonates

  • Short Report
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Benjamin JRDK, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH (2003) Empiric therapy for neonatal candidemia in very low birth weight infants. Pediatrics 112:543–547

    Article  PubMed  Google Scholar 

  2. Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF (2005) Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr 147:162–165

    Article  PubMed  CAS  Google Scholar 

  3. Feja KN, Wu F, Roberts K, Loughrey M, Nesin M, Larson E, Della-Latta P, Haas J, Cimiotti J, Saiman L (2005) Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr 147:156–161

    Article  PubMed  Google Scholar 

  4. Healy CM, Baker CJ, Zaccaria E, Campbell JR (2005) Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr 147:166–171

    Article  PubMed  CAS  Google Scholar 

  5. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB (2005) Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of<1,000 grams birth weight. J Pediatr 147:172–179

    Article  PubMed  CAS  Google Scholar 

  6. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinsosn M, Donowitz LG (2001) Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345:1660–1666

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Drs. Mauro Bohrer, Ernani Miura, Clovis Weissheimer and Clarice Giacomini for their assistance in discussing the guideline and their adherence to our institutional guideline.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Newborn Section, Universidade Federal do Rio Grande do Sul and Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil

    Mariluce V. Enéas & Rita C. Silveira

  2. Department of Pediatrics, Newborn Section, Universidade Federal do Rio Grande do Sul and Hospital de Clínicas de Porto Alegre, Rua Tobias da Silva 99, #302, Porto Alegre, RS, 90570-020, Brazil

    Renato S. Procianoy

Authors
  1. Renato S. Procianoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariluce V. Enéas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rita C. Silveira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renato S. Procianoy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Procianoy, R.S., Enéas, M.V. & Silveira, R.C. Empiric guidelines for treatment of Candida infection in high-risk neonates. Eur J Pediatr 165, 422–423 (2006). https://doi.org/10.1007/s00431-006-0088-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-006-0088-1

Keywords

Search

Navigation